会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran
    • 放射性标记二亚乙基三胺五乙酸(DTPA) - 葡聚糖的组合物
    • US08545808B2
    • 2013-10-01
    • US13461306
    • 2012-05-01
    • Gerald Ross MagnesonRichard Cushman Orahood
    • Gerald Ross MagnesonRichard Cushman Orahood
    • A61K51/00A01N59/16
    • C07B59/005A61K51/0491A61K51/065C07B59/001C07B59/004C07B63/04C07B2200/05G01N33/534G01N33/60
    • The subject invention relates to the compositions for radiolabeling Diethylenetriaminepentaacetic Acid (DTPA)-dextran with Technetium-99m and for stabilizing the DTPA-dextran Cold Kit. The composition contains Stannous Chloride ions to reduce 99mTc-pertechnetate, Ascorbic Acid to reduce stannic ions to stannous ions to maintain a reducing environment, α,α-Trehalose to add bulk and to stabilize the lyophilized composition without interfering with the radiochemical yield, and Glycine to transchelate Technetium-99m under highly acidic conditions to facilitate radiolabeling DTPA-dextran with high radiochemical purity. In addition, the invention pertains to methods for making and using the compositions. The reconstitution of the lyophilized composition by 99mTc-pertechnetate, resulting in radiolabeled 99mTc-DTPA-dextran in a composition between pH 3 to 4. This invention contains a Diluent vial, which when used will shift the pH to a moderately acidic pH, which would provide less pain on injection and ease-of-use to clinical practitioners for adjusting its potency.
    • 本发明涉及用锝-99m放射性标记二亚乙基三胺五乙酸(DTPA) - 葡聚糖并用于稳定DTPA-葡聚糖冷试剂盒的组合物。 该组合物含有氯化亚锡离子以减少99mTc-高锝酸盐,抗坏血酸将亚锡离子还原成亚锡离子以保持还原环境,α,α-海藻糖增加体积并稳定冻干组合物而不干扰放射化学产率,甘氨酸 在高度酸性条件下将锝-99m转移以便放射性标记具有高放射化学纯度的DTPA-葡聚糖。 此外,本发明涉及制备和使用组合物的方法。 通过99mTc-高锝酸盐重构冻干组合物,得到在pH3-4之间的组合物中放射性标记的99mTc-DTPA-葡聚糖。本发明含有稀释剂小瓶,其使用时将pH值移至中等酸性pH值, 为临床医师提供更少的注射疼痛和易于使用的调节效力。
    • 2. 发明申请
    • COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN
    • 用于放射性二甲基氨基苯甲酸(DTPA)-DEXTRAN的组合物
    • US20120213700A1
    • 2012-08-23
    • US13461306
    • 2012-05-01
    • Gerald Ross MagnesonRichard Cushman Orahood
    • Gerald Ross MagnesonRichard Cushman Orahood
    • A61K51/00B65B1/04
    • C07B59/005A61K51/0491A61K51/065C07B59/001C07B59/004C07B63/04C07B2200/05G01N33/534G01N33/60
    • The subject invention relates to the compositions for radiolabeling Diethylenetriaminepentaacetic Acid (DTPA)-dextran with Technetium-99m and for stabilizing the DTPA-dextran Cold Kit. The composition contains Stannous Chloride ions to reduce 99mTc-pertechnetate, Ascorbic Acid to reduce stannic ions to stannous ions to maintain a reducing environment, α,α-Trehalose to add bulk and to stabilize the lyophilized composition without interfering with the radiochemical yield, and Glycine to transchelate Technetium-99m under highly acidic conditions to facilitate radiolabeling DTPA-dextran with high radiochemical purity. In addition, the invention pertains to methods for making and using the compositions. The reconstitution of the lyophilized composition by 99mTc-pertechnetate, resulting in radiolabeled 99mTc-DTPA-dextran in a composition between pH 3 to 4. This invention contains a Diluent vial, which when used will shift the pH to a moderately acidic pH, which would provide less pain on injection and ease-of-use to clinical practitioners for adjusting its potency.
    • 本发明涉及用锝-99m放射性标记二亚乙基三胺五乙酸(DTPA) - 葡聚糖并用于稳定DTPA-葡聚糖冷试剂盒的组合物。 该组合物含有氯化亚锡离子以减少99mTc-高锝酸盐,抗坏血酸将亚锡离子还原成亚锡离子以保持还原环境,α,α-海藻糖增加体积并稳定冻干组合物而不干扰放射化学产率,甘氨酸 在高度酸性条件下将锝-99m转移以便放射性标记具有高放射化学纯度的DTPA-葡聚糖。 此外,本发明涉及制备和使用组合物的方法。 通过99mTc-高锝酸盐重构冻干组合物,得到在pH3-4之间的组合物中放射性标记的99mTc-DTPA-葡聚糖。本发明含有稀释剂小瓶,其使用时将pH值移至中等酸性pH值, 为临床医师提供更少的注射疼痛和易于使用的调节效力。
    • 3. 发明申请
    • COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN
    • 用于放射性二甲基氨基苯甲酸(DTPA)-DEXTRAN的组合物
    • US20100196272A1
    • 2010-08-05
    • US12362778
    • 2009-01-30
    • Gerald Ross MagnesonRichard Cushman Orahood
    • Gerald Ross MagnesonRichard Cushman Orahood
    • A61K51/04
    • C07B59/005A61K51/0491A61K51/065C07B59/001C07B59/004C07B63/04C07B2200/05G01N33/534G01N33/60
    • The subject invention relates to the compositions for radiolabeling Diethylenetriaminepentaacetic Acid (DTPA)-dextran with Technetium-99m and for stabilizing the DTPA-dextran Cold Kit. The composition contains Stannous Chloride ions to reduce 99mTc-pertechnetate, Ascorbic Acid to reduce stannic ions to stannous ions to maintain a reducing environment, α,α-Trehalose to add bulk and to stabilize the lyophilized composition without interfering with the radiochemical yield, and Glycine to transchelate Technetium-99m under highly acidic conditions to facilitate radiolabeling DTPA-dextran with high radiochemical purity. In addition, the invention pertains to methods for making and using the compositions. The reconstitution of the lyophilized composition by 99mTc-pertechnetate, resulting in radiolabeled 99mTc-DTPA-dextran in a composition between pH 3 to 4. This invention contains a Diluent vial, which when used will shift the pH to a moderately acidic pH, which would provide less pain on injection and ease-of-use to clinical practioners for adjusting its potency.
    • 本发明涉及用锝-99m放射性标记二亚乙基三胺五乙酸(DTPA) - 葡聚糖并用于稳定DTPA-葡聚糖冷试剂盒的组合物。 该组合物含有氯化亚锡离子以减少99mTc-高锝酸盐,抗坏血酸将亚锡离子还原成亚锡离子以保持还原环境,α,α-海藻糖增加体积并稳定冻干组合物而不干扰放射化学产率,甘氨酸 在高度酸性条件下将锝-99m转移以便放射性标记具有高放射化学纯度的DTPA-葡聚糖。 此外,本发明涉及制备和使用组合物的方法。 通过99mTc-高锝酸盐重构冻干组合物,得到在pH3-4之间的组合物中放射性标记的99mTc-DTPA-葡聚糖。本发明含有稀释剂小瓶,其使用时将pH值移至中等酸性pH值, 为临床工作者提供更少的注射痛苦和易用性,以调整其效力。